Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAJLJ8WuczC6uwrh7JfdKAEvqA8m-7bcSOdeAELOqKiCM#assertion>. }
Showing items 1 to 19 of
19
with 100 items per page.
- DB00363 type Drug assertion.
- MONDO_0005414 type Disease assertion.
- context type Cohort assertion.
- association type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.
- DB00363 label "Clozapine" assertion.
- MONDO_0005414 label "Schizophrenia" assertion.
- context label "Children and adolescents" assertion.
- association label "There are no FDA or manufacturer guidelines for use of clozapine in pediatric population. Clozapine has been used in the treatment of refractory schizophrenia in child and adolescents. It is estimated that 40%–50% of patients with very early-onset schizophrenia (VEOS) are nonresponders to first-line neuroleptics and that clozapine is likely to be beneficial." assertion.
- association subject DB00363 assertion.
- association predicate treats assertion.
- association object MONDO_0005414 assertion.
- association has_population_context context assertion.
- association relation NCIT_C94303 assertion.
- DB00363 category Drug assertion.
- MONDO_0005414 category Disease assertion.
- context category Cohort assertion.
- association category ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.
- association publications 31082865 assertion.
- association aggregator_knowledge_source knowledge-collaboratory assertion.